(Q42670877)

4 November 2017

title

Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome (English)

1 reference

4 November 2017

1 reference

Appel-Dingemanse S

1

1 reference

4 November 2017

Smith T

series ordinal

2

1 reference

4 November 2017

Merz M

series ordinal

3

1 reference

4 November 2017

publication date

1 March 2002

1 reference

The Journal of Clinical Pharmacology

4 November 2017

published in

1 reference

4 November 2017

volume

42

1 reference

4 November 2017

issue

3

1 reference

4 November 2017

page(s)

312-318

1 reference

Fluvastatin: a review of its use in lipid disorders

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Lipid-lowering treatment in coronary artery disease: how low should cholesterol go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

The effect of HMG-CoA reductase inhibitors on chronic allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Impact of dyslipidaemia in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Functional relationships in the nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Hyperlipidemia in renal transplant recipients: natural history and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Role of circulating lipid abnormalities in chronic renal allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Effect of fluvastatin for safely loweringatherogenic lipids in renal transplant patients receiving cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Serum lipids and hemostasis in kidney allograft recipients treated with fluvastatin (Lescol) for 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Fluvastatin in the treatment of hypercholesterolemia in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

High-performance liquid chromatographic method for the determination of fluvastatin in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Fluvastatin for dyslipoproteinemia,with or without concomitant chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Binding of fluvastatin to blood cells and plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patients with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011346

10.1177/00912700222011346

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference